Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Journal of Cancer
|
June 14, 2017
Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development
J S Berry, T J Vreeland, D F Hale, et al.
Military Medicine
|
September 16, 2022
Meeting the New Commission on Cancer Operative Standards: Where Do We Stand Now?
Elizabeth L Carpenter, Alexandra M Adams, Patrick M McCarthy, et al.
Journal of Surgical Education
|
July 2, 2021
Using the Flipped Classroom Model in Surgical Education: Efficacy and Trainee Perception
R C Chick, A M Adams, K M Peace, et al.
Surgical Endoscopy
|
November 7, 2022
Modern trends in minimally invasive versus open hepatectomy for colorectal liver metastasis: an analysis of ACS-NSQIP
E L Carpenter, K K Thomas, A M Adams, et al.
Oncotargets and Therapy
|
June 9, 2021
Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma
Patrick M McCarthy, Matthew J Rendo, Matthew D Uy, et al.
Immunotherapy
|
February 24, 2018
Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine
Mark O Hardin, Timothy J Vreeland, Guy T Clifton, et al.
Journal of Thermal Biology
|
February 19, 2026
Ecological overlap and divergence in natural and urbanized habitats in two species of sympatric anoles
Noah D Gripshover, Elizabeth G Hoffman, Gauthier Alexandrescu, et al.
Vaccine
|
May 5, 2018
Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors
Garth S Herbert, Timothy J Vreeland, Guy T Clifton, et al.
Clinical Immunology (Orlando, Fla.)
|
March 26, 2018
Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response
Timothy J Vreeland, Jennifer K Litton, Na Qiao, et al.
Annals of Surgical Oncology
|
May 18, 2022
Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival
Anne E O'Shea, Phillip M Kemp Bohan, Elizabeth L Carpenter, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Journal of Cancer
|
June 14, 2017
Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development
J S Berry, T J Vreeland, D F Hale, et al.
Military Medicine
|
September 16, 2022
Meeting the New Commission on Cancer Operative Standards: Where Do We Stand Now?
Elizabeth L Carpenter, Alexandra M Adams, Patrick M McCarthy, et al.
Journal of Surgical Education
|
July 2, 2021
Using the Flipped Classroom Model in Surgical Education: Efficacy and Trainee Perception
R C Chick, A M Adams, K M Peace, et al.
Surgical Endoscopy
|
November 7, 2022
Modern trends in minimally invasive versus open hepatectomy for colorectal liver metastasis: an analysis of ACS-NSQIP
E L Carpenter, K K Thomas, A M Adams, et al.
Oncotargets and Therapy
|
June 9, 2021
Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma
Patrick M McCarthy, Matthew J Rendo, Matthew D Uy, et al.
Immunotherapy
|
February 24, 2018
Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine
Mark O Hardin, Timothy J Vreeland, Guy T Clifton, et al.
Journal of Thermal Biology
|
February 19, 2026
Ecological overlap and divergence in natural and urbanized habitats in two species of sympatric anoles
Noah D Gripshover, Elizabeth G Hoffman, Gauthier Alexandrescu, et al.
Vaccine
|
May 5, 2018
Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors
Garth S Herbert, Timothy J Vreeland, Guy T Clifton, et al.
Clinical Immunology (Orlando, Fla.)
|
March 26, 2018
Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response
Timothy J Vreeland, Jennifer K Litton, Na Qiao, et al.
Annals of Surgical Oncology
|
May 18, 2022
Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival
Anne E O'Shea, Phillip M Kemp Bohan, Elizabeth L Carpenter, et al.
Page
of 8